going from mounjaro to retatrutide vs (UK): the simple, evidence‑based guide Retatrutide vs Mounjaro: The Truth

Support Health Rising and Keep the Information Flowing

To qualify, a person must be enrolled in a Medicare Part D plan and meet one of three clinical criteriaassessed at the time you first started GLP-1 therapy, not at the time you apply: BMI of 35 or higher (no additional diagnosis required) BMI of 30 or higher, plus a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension on two or more blood pressure medications, or chronic kidney disease stage 3a or higher BMI of 27 or higher, plus a diagnosis of pre-diabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease Your provider submits a prior authorization request attesting you meet the criteriayou dont need to opt in or take any action yourself

He also has a fantastic skin care line thats very reasonable

The Honest Evidence Summary Any honest coverage of the blood pressure supplement category needs to acknowledge what the scientific literature actually says - the full picture, not just the citations that support the marketing narrative

Conclusion: When and how to safely switch GLP-1 medications GLP-1 medications have complex dosing schedules

PHQ-A depression screen